Morgan Lewis

Life Sciences Transactions Publications of Interest

For More Information

Read the brochure

Emerging Business Tools

visit the Entrepreneur Resource Headquarters

Related Publications

10/28/10 Preparing for a Biotechnology M&A – Corporate and Regulatory Insight to Keep Ahead of the Competition
(pdf)
06/19/08 From Europe and Japan to the U.S.: Build or Buy?, presented at the 2008 BIO International Convention, San Diego, CA
05/24/05 Pharmaceutical Industry Mergers: Anticipating Antitrust Issues and Surviving the Investigation, presented at the American Conference Institute In-House Counsel Forum on Pharmaceutical Antitrust, Washington, D.C.
View all publications

Related News

04/11/13 Morgan Lewis Advises MEI Pharma on $15.2 Million Registered Offering of Common Stock
Morgan Lewis served as legal adviser to MEI Pharma, Inc. on registered offering of common stock.
10/29/10 Morgan Lewis Advises Safeguard Scientifics on $587 Million Sale of Clarient to GE Healthcare
In a transaction valued at $587 million, Clarient, Inc. has agreed to be acquired by GE Healthcare.
10/28/10 Morgan Lewis Advises BMP Sunstone on Acquisition by Sanofi-Aventis
BMP Sunstone and sanofi-aventis announced that they have entered into a definitive agreement where sanofi-aventis will acquire all outstanding shares of BMP Sunstone at $10 per share, or approximately $520.6 million.
View all news

Honors

BioPharm Insight 2012

  • Ranked 3rd - Global League Table of Legal Advisers to Biotech and Pharma Licensing Agreements - Based upon Value
  • Ranked 4th - Global League Table of Legal Advisers to Biotech and Pharma Licensing Agreements - Based upon Volume
  • Ranked 10th - Legal Advisors to Biotech and Pharma Licensing Agreements: North America - Based upon Value
  • Ranked 5th - Legal Advisors to Biotech and Pharma Licensing Agreements: North America - Based upon Volume
  • Ranked 2nd - Legal Advisors to Biotech and Pharma Licensing Agreements: Europe - Based upon Value
  • Ranked 3rd - Legal Advisors to Biotech and Pharma Licensing Agreements: Europe - Based upon Volume
  • Ranked 2nd - Legal Advisors to Biotech and Pharma Licensing Agreements: Asia-Pacific - Based upon Value
  • Ranked 3rd - Legal Advisors to Biotech and Pharma Licensing Agreements: Asia-Pacific - Based upon Volume
15 Publications Found
page 1 of 1
10/28/10 Preparing for a Biotechnology M&A – Corporate and Regulatory Insight to Keep Ahead of the Competition

Presentation | Speech
Stephen Mahinka, Richard Aldridge

06/19/08 From Europe and Japan to the U.S.: Build or Buy?, presented at the 2008 BIO International Convention, San Diego, CA

Presentation | Speech
Randall Sunberg

05/24/05 Pharmaceutical Industry Mergers: Anticipating Antitrust Issues and Surviving the Investigation, presented at the American Conference Institute In-House Counsel Forum on Pharmaceutical Antitrust, Washington, D.C.

Presentation | Speech
Stephen Mahinka

10/29/04 Making 50-50 Collaborations Work Effectively, presented to JP Morgan Chase, Newport Conference Center

Presentation | Speech
Randall Sunberg

10/17/04 Biotech and Pharma M&A and Collaborations: Protecting the Deal and Preserving Your Upside, LES Annual Meeting, Boston

Presentation | Speech
Randall Sunberg

10/13/04 Outline of Issues for a Biotech Company to Consider in Preparing for an IPO

Presentation | Speech
Steven Cohen

10/05/04 Biotech and Pharma M&A and Collaborations: Protecting the Deal and Preserving Your Upside, presented at Biotech 2004, Philadelphia

Presentation | Speech
Randall Sunberg

July/August 2004 Morgan Lewis on Life Sciences
July/August 2004

Newsletter | Morgan Lewis on Life Sciences
Life Sciences

In this Issue: FDA Issues Draft Guidances on Advertising and Promotion: The Food and Drug Administration released three new draft guidance documents regarding direct–to–consumer (DTC) advertisements of drugs, biolo... more

07/24/04 Strategic Alliances and Business Development, presented at the BioForum 2004, Shanghai

Presentation | Speech
Randall Sunberg

02/13/04 Protecting Your Downside While Maximizing Your Upside: Protective Provisions in Biotech Deals, presented at the LES Winter Meeting, San Francisco

Presentation | Speech
Randall Sunberg

09/09/03 Pharma and Biotech Collaborations, PA Biotech, 3 Rivers Venture Fair

Presentation | Speech
Randall Sunberg

06/24/03 Getting from Biotech to BIG Biotech, BIO 2003, Washington, DC

Presentation | Speech
Randall Sunberg

04/30/03 Closing Plenary Session: Facilitating Global Reach in the Life Sciences Industry, BIOTechnica America, Monterey, CA

Presentation | Speech
Randall Sunberg

January/February 2003 Morgan Lewis on Life Sciences
January/February 2003

Newsletter | Morgan Lewis on Life Sciences
Life Sciences

In this Issue: A Shift in the Hatch-Waxman Balance: FDA's Proposed Rule: The Hatch-Waxman Act, which created today’s generic drug system, was premised on balancing two divergent interests — facilitating the approval... more

July 2002 Morgan Lewis on Life Sciences
July 2002

Newsletter | Morgan Lewis on Life Sciences
Life Sciences

In this Issue: Welcome and Introduction BuSpar® and Tiazac® Antitrust Cases Leave Unanswered Questions: Over the last few years, an increasing number of antitrust cases have challenged various action... more

page 1 of 1